SCHEMBL6976538

SCHEMBL6976538

O=S(=O)(Nc1ccc2c(c1)CCCN2)c1ccc2ccccc2c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 3/20 0.65
NLRP3 Q96P20 1/20 0.54
SMN1; SMN2 Q16637 3/20 0.53
LMNA P02545 2/20 0.53
PKLR P30613 1/20 0.53
ATM Q13315 1/20 0.52
KMT2A Q03164 5/20 0.52
BRD4 O60885 2/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA9 Q16790 1/20 0.50
PGR P06401 1/20 0.50
NR3C1 P04150 1/20 0.49
MEN1 O00255 4/20 0.49
PNMT P11086 1/20 0.48
ALDH1A1 P00352 3/20 0.48
MAPT P10636 2/20 0.48
HTT P42858 1/20 0.48
GAA P10253 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6984820 0.86 HTR6 (0.61) PKMSMN1; SMN2LMNAKMT2ABRD4
SCHEMBL31681377 0.84 EIF2AK2 (0.54) PKMNLRP3SMN1; SMN2LMNABRD4
SCHEMBL2229992 0.84 HTR2C (0.61) PKMSMN1; SMN2KMT2ABRD4CA12
SCHEMBL1009369 0.82 PLAU (0.49) PKMSMN1; SMN2LMNAKMT2ACA12
SCHEMBL6985319 0.81 CA12 (0.53) PKMSMN1; SMN2LMNACA12CA1
SCHEMBL6986758 0.81 PKM (0.56) PKMSMN1; SMN2LMNAKMT2ABRD4
SCHEMBL6985107 0.81 LMNA (0.67) PKMSMN1; SMN2LMNABRD4CA12
SCHEMBL6982218 0.81 PKM (0.56) PKMSMN1; SMN2LMNAPKLRKMT2A
SCHEMBL6983859 0.81 PKM (0.56) PKMLMNABRD4PGRMAPT
SCHEMBL6974134 0.81 HSD17B2 (0.50) PKMSMN1; SMN2LMNABRD4CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed